Drug Shortage Report for GLYCOPYRROLATE INJECTION USP

Last updated on 2022-11-29 History
Report ID 167366
Drug Identification Number 02039508
Brand name GLYCOPYRROLATE INJECTION USP
Common or Proper name GLYCOPYRROLATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML 10LIVI
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-01
Estimated end date 2022-11-18
Actual end date 2022-11-28
Shortage status Resolved
Updated date 2022-11-29
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2022-11-29 English Compare
v14 2022-11-28 French Compare
v13 2022-11-28 English Compare
v12 2022-11-28 French Compare
v11 2022-11-28 English Compare
v10 2022-10-19 French Compare
v9 2022-10-19 English Compare
v8 2022-09-21 French Compare
v7 2022-09-21 English Compare
v6 2022-09-02 English Compare
v5 2022-09-01 French Compare
v4 2022-09-01 English Compare
v3 2022-08-23 English Compare
v2 2022-08-19 French Compare
v1 2022-08-19 English Compare

Showing 1 to 15 of 15